OBJECTIVE -We sought to determine whether an oral disposition index (DI O ) predicts the development of diabetes over a 10-year period. First, we assessed the validity of the DI O by demonstrating that a hyperbolic relationship exists between oral indexes of insulin sensitivity and ␤-cell function.
T ype 2 diabetes is characterized by both insulin resistance and ␤-cell dysfunction (1) . Abnormalities in ␤-cell function are present in high-risk individuals long before they develop hyperglycemia (1) . This recognition has occurred in part because of a better understanding of the ability of the ␤-cell to regulate its insulin response to stimuli based on differences in insulin sensitivity.
Using intravenous testing, subjects with normal ␤-cell function demonstrate a hyperbolic relationship between insulin sensitivity and insulin responses (2, 3) , consistent with a classic feedback loop. On the basis of this hyperbolic relationship, the product of these two variables, referred to as the disposition index, can be calculated and has highlighted the inability of the ␤-cell to compensate for insulin resistance in subjects at risk for diabetes (4, 5) and with higher fasting glucose levels (6 -8) . In prospective studies, the disposition index declines well before glucose levels rise into the diabetic range (9) . Thus, a low disposition index is an early marker of inadequate ␤-cell compensation.
This hyperbolic relationship has been demonstrated between measures of insulin sensitivity and response derived from intravenous tests (3) as well as between the early insulin response during an oral glucose tolerance test (OGTT) and insulin sensitivity derived from intravenous testing (10) . However, intravenous tests are time-consuming, expensive, and not practical for large studies. The OGTT is less precise (11) but simpler to perform and is often used in large epidemiological or intervention studies. Recently, a nonlinear function describing the relationship between the oral glucose-induced early insulin response and insulin sensitivity has been used to assess ␤-cell function in both observational (12) and interventional studies (13) . Using OGTT measures, Retnakaran et al. (14) were able to show a hyperbolic relationship between insulin sensitivity (Matsuda index) and the incremental area under the curve insulin/glucose (incAUC ins/glu ) response but not the early insulin response. Sakaue et al. (15) also failed to demonstrate a hyperbolic relationship between OGTTderived insulin sensitivity and the early insulin response. However, the latter regression analysis failed to account for measurement error in the independent variable, which leads to an underestimation of the slope (16).
We first tested whether the relationship between the early insulin response or the incAUC ins/glu response after oral glucose and surrogate measures of insulin sensitivity were related in a hyperbolic manner using a regression technique that takes measurement error in both variables into account. We then tested whether this relationship exists for different glucose tolerance categories. Finally, as we found the relationship to be hyperbolic, we examined whether a composite measure (oral disposition index) is associated with the development of diabetes.
RESEARCH DESIGN AND METHODS -The Japanese American
Community Diabetes Study was conducted in King County, Washington, with baseline testing performed between 1983 and 1988 and follow-up examinations ϳ5 and 10 years later. The design and methods used in this study have been described previously (17) . The study was approved by the local institutional review board, and written informed consent was obtained from each participant.
Baseline oral glucose tolerance testing was performed in 658 subjects; 640 subjects had complete data for insulin and glucose values at basal, 30 min, and 120 min. Ten subjects were excluded because of negative or zero ⌬I 0 -30 /⌬G 0 -30 (n ϭ 7) or incAUC ins/glu responses (n ϭ 3). Seventeen subjects were excluded as outliers (see STA-TISTICAL METHODS). Subjects who did not have diabetes at baseline (n ϭ 498) had follow-up examinations and OGTTs at 5 or 6 years (5 year, n ϭ 448) and at 10 or 11 years (10 year, n ϭ 398).
Study procedures and assays
A standard 75-g OGTT was performed in the morning after a 10-h overnight fast. Samples were drawn just before and at 30, 60, and 120 min after ingestion of glucose. Samples were collected in EDTA, separated, and stored at Ϫ20°C before being assayed. Plasma glucose was measured by the glucose oxidase method. Plasma insulin was measured using a modified double-antibody radioimmunoassay as described previously (17) . Height, weight, and abdominal circumference (umbilicus) were measured three times at each visit, and the average for each visit was used. (19) . The early insulin response was calculated as the ratio of the change in insulin to the change in glucose from 0 to 30 min (⌬I 0 -30 /⌬G 0 -30 ). The incAUC ins/glu response was calculated by the trapezoidal method from 0 to 120 min. The composite measure of ␤-cell function, which we have termed the oral disposition index (DI O ), was calculated as ⌬I 0 -30 /⌬G 0 -30 ϫ 1/fasting insulin.
Classification of glucose tolerance

Statistical analysis
To determine whether the relationships between the dependent (⌬I 0 -30 /⌬G 0 -30 or incAUC ins/glu ) and independent (1/ fasting insulin or HOMA-S) variables were consistent with a rectangular hyperbola (x ϫ y ϭ constant), we estimated ln(⌬I 0 -30 /⌬G 0 -30 or incAUC ins/glu ) as a linear function of ln(1/fasting insulin or HOMA-S) using regression analysis. If the hyperbolic relationship exists, the slope of the regression line should not be significantly different from Ϫ1. When error is present in both x and y variables, the slope that is determined by ordinary leastsquares regression is underestimated because it assumes all error in the y variable. The regression method we used corrects this bias by incorporation of a factor computed as the ratio of the variances of the error in the y to x variables (16). The error estimates for these measurements (57.1% for ⌬I 0 -30 /⌬G 0 -30 , 24.9% for incAUC ins/glu , 16.6% for 1/fasting insulin, and 16.4% for HOMA-S) were based on the day-to-day coefficients of variation in a group of subjects with various glucose tolerance (11) . A hyperbolic relationship was presumed if the 95% CI of the slope included Ϫ1. The 95% CI was calculated using the bootstrap method. Subjects were subdivided for analysis by glucose tolerance category. The y intercept of the regression line of the ln-transformed variables was calculated, assuming a slope of Ϫ1.
Because outlying values can have marked adverse effects on regression parameters, the data were subjected to a series of tests for influential values, specifically, Cooks distance, DFBETA, DFFIT, COVRatio, and HATvalue using the R statistical procedure "influence measures" (20) . Because of the high number of data points, the critical value for each test was set such that the ␣ (type 1 error) was Ͻ0.002. A data point that was identified as an influential point by any of these tests was reviewed graphically, and the subject was eliminated from further analysis.
To exclude the possibility that the regression is artifactual-driven by fasting insulin and glucose appearing in both the insulin sensitivity and ⌬I 0 -30 /⌬G 0 -30 equations-the same regression procedures were performed on the data except that the 30-min insulin values were shuffled using the Fisher-Yates algorithm to remove any physiological relationship. This shuffle-regression procedure was repeated 100,000 times, and the median and 95% CIs were determined. These simulations showed that only a weak, positive slope resulted with wide confidence limits that did not include Statistical analysis was performed using STATA (version 9.0; StataCorp, College Station, TX). Variables that were not normally distributed were log e transformed to achieve a normal distribution. ANOVA with a post hoc Scheffe correction was performed to compare variables between different glucose tolerance categories. Multiple logistic regression analysis was performed to determine whether DI O was independently associated with cumulative diabetes (yes/no) at 10 years. Only subjects without diabetes at baseline were included in this analysis. A diagnosis of diabetes at 5 years was carried forward and included in the cumulative 10-year incidence. The model included ln(DI O ), ln(age), sex, ln-(BMI), ln(fasting glucose), and ln(2-h glucose). In addition, subjects without diabetes at baseline were divided into quintiles of baseline DI O , and the multiple logistic regression analysis was rerun.
To determine whether DI O was a better predictor of diabetes than 1/fasting insulin or ⌬I 0 -30 /⌬G 0 -30 alone, nonparametric receiver operating characteristic (ROC) curve analysis was performed with cumulative diabetes at 10 years (no) as the outcome variable. An optimal cut point for DI O was obtained using the Youden index (maximum [sensitivity ϩ specificity -1]). P Ͻ 0.05 was considered statistically significant.
RESULTS -The 613 subjects were categorized by glucose tolerance on the basis of their fasting and 2-h plasma glucose measurements (Table 1) . Fasting insulin, HOMA-S, and ⌬I 0 -30 /⌬G 0 -30 did not differ between isolated IFG (iIFG), isolated IGT (iIGT), and IFG ϩ IGT groups. Thus, these groups were combined for analysis into the IGM group. Age, BMI, and abdominal circumference increased progressively with deteriorating glucose metabolism, whereas insulin sensitivity and insulin responses decreased progressively from NGT to IGM to diabetes (Table 1) .
Hyperbolic relationship between insulin sensitivity and insulin responses in subjects with NGT The 95% CI for the regression slopes included Ϫ1 for the relationship between ln(1/fasting insulin) and both ln(⌬I 0 -30 / ⌬G 0 -30 ) (slope Ϫ0.87 [95% CI Ϫ1.13 to Ϫ0.61]) (Fig. 1A) The hyperbolic curves demonstrated a shift to the left and downward from NGT to IGM to diabetes (⌬I 0 -30 /⌬G 0 -30 versus 1/fasting insulin) (Fig. 1D ). Similar shifts were seen when HOMA-S or incAUC ins/glu was used. This decrease in ␤-cell function is best evaluated by examination of the y intercepts for the ln-ln relationships. These intercepts decreased from NGT (mean Ϯ SD 0.53 Ϯ 0. On the basis of the hyperbolic relationship between ⌬I 0 -30 /⌬G 0 -30 and 1/fasting insulin, the product of these two variables (DI O ) was computed as a composite measure of ␤-cell function. DI O decreased progressively from NGT to IGM to diabetes (P Ͻ 0.001 for all comparisons) (Fig. 2A) DI O was associated with the development of diabetes over 10 years Subjects who progressed to diabetes over the 10-year follow-up period ("progressors": n ϭ 9 with baseline NGT and n ϭ 84 with baseline IGM) were compared with those who did not progress ("nonprogressor": n ϭ 235 with baseline NGT and n ϭ 170 with baseline IGM , P Ͻ 0.001). The relationship between insulin sensitivity and insulin response at baseline was shifted downward and to the left in the progressors compared with the nonprogressors (Fig. 2B) .
We examined whether DI O was an independent predictor of the development of diabetes over time. In subjects who did not have diabetes at baseline, a higher DI O was associated with a decreased risk of diabetes at 10 years (odds ratio (Fig.  2C) .
ROC curve analysis was performed to determine whether the composite measure DI O was better at predicting protection from diabetes compared with ⌬I 0 -30 / ⌬G 0 -30 or 1/fasting insulin alone. The area under the ROC curve was highest using DI O (Fig. 2D) . The best predictor for remaining without dia- betes was DI O Ն1.24 (sensitivity of 59.3% and specificity of 79.6%).
CONCLUSIONS -A hyperbolic relationship between insulin sensitivity and responses using intravenous measures (3) has been widely accepted. This study demonstrates that measures of insulin sensitivity and response derived from an OGTT are also compatible with a hyperbolic association and that this relationship is present not only in subjects with NGT but also in subjects with IGM and diabetes. Importantly, the existence of this relationship allows calculation of a DI O , which was predictive of future development of diabetes above and beyond traditional risk factors, such as family history and fasting and 2-h glucose levels. The DI O as a composite measure was a better predictor for diabetes than either ⌬I 0 -30 / ⌬G 0 -30 or 1/fasting insulin alone.
Our finding that the relationship between insulin sensitivity and insulin response based on OGTT measures is shifted downward and to the left as glucose tolerance deteriorates is consistent with previous work using intravenous tests (6, 21) . With the use of intravenous measures, the disposition index was lower at baseline and declined further in those whose glucose metabolism deteriorated over time (9, 21, 22) . Our current findings extend use of this approach to measure ␤-cell function using OGTTderived measures. Importantly, we have shown that the DI O was inversely correlated with the risk of future diabetes. Thus, the DI O may be useful to help identify subjects in large epidemiological studies who have an increased risk of developing diabetes.
The statistical methodology for assessment of this hyperbolic relationship is critical when both the x and y variables are measured with error, as the slope will be underestimated if measurement error in the independent variable is not accounted for (23) . The absence of a hyperbolic relationship between these same OGTT measures in a previously published study (15) may have been due to this issue. Although Retnekaran et al. (14) did account for error estimates in both variables, the slopes for the relationships between ⌬I 0 -30 /⌬G 0 -30 and measures of insulin sensitivity (1/HOMA for insulin resistance and the Matsuda index) were ϽϪ1 (Ϫ1.61 and Ϫ1.60, respectively) and because of the wide CIs that included 0 were not considered to be hyperbolic. In contrast, we found that the slopes for subjects with NGT for the log-relationships between ⌬I 0 -30 /⌬G 0 -30 and 1/fasting insulin (slope ϭ Ϫ0.87) or HOMA-S (slope ϭ Ϫ0.91) were slightly ϾϪ1, but the CI still included Ϫ1, consistent with a hyperbolic relationship. Differences in results between our study and that by Retnakaran et al. could be due to differences in error estimates, as the slopes are quite sensitive to changes in error estimates. Of note, our results are consistent with the slope estimates for the log-relationship between the acute insulin response to glucose and the insulin sensitivity index (S I ) derived from a frequently sampled intravenous glucose tolerance test (slope ϭ Ϫ0.97) (3) or between ⌬I 0 -30 /⌬G 0 -30 and S I (slope ϭ Ϫ0.86) (10) .
The strengths of this study include the large number of subjects and the longitudinal study design. However, we failed to show a hyperbolic relationship for some regressions when the iIFG and iIGT groups were examined separately. It is possible that glucose tolerance in these subpopulations fails to follow a hyperbolic relationship, although it seems unlikely because when they are combined the hyperbolic relationship is present. In the group with diabetes, the logrelationships between ⌬I 0 -30 /⌬G 0 -30 and insulin sensitivity measures were flatter and did not include Ϫ1 when HOMA-S was used. This may reflect the much broader range of glucose tolerance (and fasting glucose levels) in this group. Finally, the CIs for the slopes using the incAUC ins/glu ratio, although including Ϫ1, were much wider and thus less reliable. Other limitations include the fact that we excluded 17 subjects (2.7%) with outlier data from this analysis, as outliers can have a disproportionate effect on regression analysis. Finally, this study was performed in Japanese Americans, and, thus, we cannot generalize the conclusions to other ethnic populations, although it is likely that the same physiological feedback processes would occur in other ethnic groups.
There are limitations to application of the DI O that need to be kept in mind. In particular, because of the increased variability of OGTT measures compared with intravenous testing, the DI O will be more variable and, hence, appropriately large sample sizes will be needed. Second, it cannot be assumed that all measures of insulin sensitivity or response will follow a hyperbolic pattern and thus simply multiplying any two measures together without first demonstrating a hyperbolic function is not appropriate. Also, it should be kept in mind that the compensatory insulin response includes both changes in insulin secretion as well as adaptations in hepatic insulin extraction (24) and changes in incretin hormone responses that may modulate both insulin secretion and hepatic insulin extraction (25) .
In summary, we have demonstrated that use of OGTT-derived measures of insulin response and insulin sensitivity can delineate differences in ␤-cell function between glucose tolerance categories. Furthermore, the composite measure DI O can be used to assess ␤-cell function and was independently associated with future diabetes risk. Thus, the disposition index approach using these specific measures offers a way to assess ␤-cell function using an OGTT and could be used to identify subjects with poor ␤-cell function for intervention trials and to assess the impact of interventions in large clinical studies.
